Neural Control of Real-Time Walking in people with Parkinson’s disease
Objective: To study the neural activity related to real-time walking in people with Parkinson’s (PwP) using a novel [18F]fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) protocol and…Normative Data for the IDEA Dementia Screen in Healthy Older Adults and People with Parkinson’s Disease in Ethiopia: A Comparative Cross Sectional Study
Objective: This study aims to establish Ethiopian normative data for IDEA in healthy older adults and People with Parkinson's disease, and to evaluate its appropriateness…Global Momentum in Parkinson’s Disease Therapeutics: Ten-Year Trends in Mechanisms, Modalities, and Clinical Endpoints
Objective: To characterize current trends in Parkinson’s disease (PD) clinical development by analyzing global interventional trials from the past decade, focusing on trial phase distribution,…Unveiling Oculomotor Phenotypes in Parkinson’s Disease: A Multidimensional Clustering Analysis
Objective: To characterize distinct Parkinson’s Disease (PD) oculomotor phenotypes and evaluate their correlation with motor severity, cognitive function, and non-motor symptom (NMS) profiles using unsupervised…Early-Onset and Familial Parkinson’s Disease in Kyrgyzstan: A PD Cohort Subset for Family-Based Genetic Studies
Objective: To characterize early-onset and familial PD cases within a Kyrgyz PD cohort and assess their potential for future family-based genetic studies. Background: Early-onset PD…Impact of Multi-day Wearable Monitoring on Neurologists’ Assessment of Motor Fluctuations and Treatment Strategies in Parkinson’s Disease: A Real-World Study
Objective: To assess the impact of wearable-device objective metrics on neurologists’ perception and therapeutic decisions in a real-world cohort of patients with Parkinson’s disease (PD).…Improving Community Access to Parkinson’s Disease Clinical Trials: Protocol for a Regional Navigation Toolkit in Southern California
Objective: To develop and pilot a regional Clinical Trials Navigation Toolkit to improve community neurologist awareness of Parkinson’s disease (PD) clinical trials and support equitable…Toward Global Best Practices for Managing Skin Complications in Subcutaneous Infusion Therapy for Parkinson’s Disease: A Nursing and Advanced Practice Perspective
Objective: The International Parkinson’s Disease Nurse and Advanced Practice Study Group within the International Parkinson’s and Movement Disorder Society conducted this survey to identify current…The Impact of Dopamine-Induced Impulse Control Disorders on Quality of Life in Young-Onset Parkinson’s Disease
Objective: To quantify how impulse control disorders (ICDs) alter day-to-day functionality and overall quality of life (QoL) among individuals living with Young-Onset Parkinson’s Disease (YOPD),…Micro- and Nanoplastics in Parkinson’s Disease Pathogenesis An Emerging Environmental Risk Factor
Objective: To synthesize current experimental and translational evidence supporting the hypothesis that micro- and nanoplastics (MNPs) may contribute to Parkinson’s disease (PD) pathogenesis through neuroinflammatory…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 553
- Next Page »